Mutational spectrum of p53 mutations in primary breast and ovarian tumors
Open Access
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 52 (2) , 103-116
- https://doi.org/10.1016/j.critrevonc.2004.07.002
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epitheliumJournal of Cellular Physiology, 2003
- A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumorsCancer, 2003
- Apoptosis: A Link between Cancer Genetics and ChemotherapyPublished by Elsevier ,2002
- Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patientsEuropean Journal Of Cancer, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- p53 mutations in BRCA1-associated familial breast cancerThe Lancet, 1998
- An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisEuropean Journal Of Cancer, 1995
- P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significanceEuropean Journal Of Cancer, 1994
- High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA AneuploidyJapanese Journal of Cancer Research, 1992
- Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast CancerJapanese Journal of Cancer Research, 1991